Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorg van Loosdregt

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN VariantsRemco G A Erkens, Jorg J A Calis, Anouk Verwoerd, et al.
Immunity|August 20, 2013
Canonical Wnt signaling negatively modulates regulatory T cell functionJorg van Loosdregt, Veerle Fleskens, Machteld M Tiemessen, et al.
Pediatric Rheumatology Online Journal|September 17, 2018
Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocolCasper G Schoemaker, Wineke Armbrust, Joost F Swart, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN VariantsRemco G A Erkens, Jorg J A Calis, Anouk Verwoerd, et al.
Immunity|August 20, 2013
Canonical Wnt signaling negatively modulates regulatory T cell functionJorg van Loosdregt, Veerle Fleskens, Machteld M Tiemessen, et al.
Pediatric Rheumatology Online Journal|September 17, 2018
Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocolCasper G Schoemaker, Wineke Armbrust, Joost F Swart, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 6